Warning: The NCBI web site requires JavaScript to function. more...
A success story: HIV prevention for injection drug users in Rhode Island.
Beckwith CG, Moreira CC, Aboshady HM, Zaller N, Rich JD, Flanigan TP.
Subst Abuse Treat Prev Policy. 2006 Dec 4;1:34.
Related citations
Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island.
Mitty JA, Bazerman LB, Selwyn K, Beckwith CG, Zaller ND, Rich JD.
AIDS Read. 2008 Dec;18(12):596-600.
Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in northern Vietnam and southern China.
Hammett TM, Kling R, Johnston P, Liu W, Ngu D, Friedmann P, Binh KT, Dong HV, Van LK, Donghua M, Chen Y, Jarlais DC.
AIDS Educ Prev. 2006 Apr;18(2):97-115.
Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD.
J Urban Health. 2010 Dec;87(6):942-53.
HIV and HCV testing for young drug users in Rhode Island.
Pugatch D, Anderson BJ, O'Connell JV, Elson LC, Stein MD.
J Adolesc Health. 2006 Mar;38(3):302-4.
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.
Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE.
J Urban Health. 2006 Jan;83(1):86-100. Review.
Lower syringe sharing and re-use after syringe legalization in Rhode Island.
Rich JD, Hogan JW, Wolf F, DeLong A, Zaller ND, Mehrotra M, Reinert S.
Drug Alcohol Depend. 2007 Jul 10;89(2-3):292-7. Epub 2007 Mar 26.
Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users.
Rich JD, Dickinson BP, Liu KL, Case P, Jesdale B, Ingegneri RM, Nolan PA.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S140-1. No abstract available.
Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island.
Rich JD, Whitlock TL, Towe CW, McKenzie M, Runarsdottir V, Aboagye-Kumi M, Burris S.
Subst Use Misuse. 2001 Apr;36(5):535-50.
Syringe access for injection drug users in Rhode Island.
Boutwell A, Rich JD.
Med Health R I. 2004 Jan;87(1):15-6. No abstract available.
HIV risk behavior among injection drug users in Tehran, Iran.
Razani N, Mohraz M, Kheirandish P, Malekinejad M, Malekafzali H, Mokri A, McFarland W, Rutherford G.
Addiction. 2007 Sep;102(9):1472-82. Epub 2007 Jul 23.
Predictors of bacterial infections among HCV-negative injection drug users in Rhode Island.
Phillips KT, Anderson BJ, Stein MD.
Am J Drug Alcohol Abuse. 2008;34(2):203-10.
HIV prevention for injecting drug users: the first 25 years and counting.
Des Jarlais DC, Semaan S.
Psychosom Med. 2008 Jun;70(5):606-11. Epub 2008 Jun 2. Review.
A syringe prescription program to prevent infectious disease and improve health of injection drug users.
Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, McNamara S, Mehrotra M, Stein MD.
J Urban Health. 2004 Mar;81(1):122-34.
HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.
Tempalski B, Lieb S, Cleland CM, Cooper H, Brady JE, Friedman SR.
J Urban Health. 2009 Jan;86(1):132-54. Epub 2008 Nov 18.
Multilevel analysis of HIV related risk behaviors among heroin users in a low prevalence community.
Li H, Goggins W, Lee SS.
BMC Public Health. 2009 May 12;9:137.
Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS.
PLoS One. 2008;3(10):e3608. Epub 2008 Oct 31.
Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.
Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S58-61.
Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
Mathers BM, Degenhardt L, Adam P, Toskin I, Nashkhoev M, Lyerla R, Rugg D.
J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S132-42.
Needle exchanges do not boost drug use, study says. IDU remains major HIV risk factor.
[No authors listed]
AIDS Alert. 2003 Sep;18(9):112, 114.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on